Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.8.0.1
Consolidated Balance Sheets - USD ($)
Sep. 30, 2017
Dec. 31, 2016
Current Assets:    
Cash and cash equivalents $ 2,732,000 $ 19,000
Prepaid expenses 0 2,000
Total Current Assets 2,732,000 21,000
Goodwill 253,777,000 0
Deposits 9,000 0
Fixed assets, net 2,000 4,000
Total Other Assets 253,788,000 4,000
TOTAL ASSETS 256,520,000 25,000
Current Liabilities:    
Accounts payable 2,714,000 2,100,000
Accrued interest 0 3,800,000
Accrued expenses 57,000 219,000
Line of credit 31,000 31,000
Warrant liability 0 417,000
Settlement note payable 0 691,000
Demand notes payable 0 452,000
Convertible debentures, net of discount of $000 and $764,000, current portion 0 10,350,000
Convertible debentures 0 889,000
Total Current Liabilities 2,802,000 18,949,000
Long term liabilities:    
Total liabilities 2,802,000 18,949,000
Stockholders' Deficit:    
Convertible preferred stock - $0.001 par value; 15,000,000 shares authorized: Series C 0 96,230 and 96,230 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively 1,000 1,000
Series H – 000 and 25,000 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively 0 0
Series I – 000 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively 0 2,000
Series J – 1,513,548 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively 1,000 0
Common stock 0 $0.001 par value; 750,000,000 shares authorized; and 49,767,978 and 104,218 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively 50,000 0
Additional paid-in capital 515,706,000 105,891,000
Accumulated deficit (261,870,000) (124,649,000)
Noncontrolling interest (169,000) (169,000)
Total Stockholders’ Equity (Deficit) 253,718,000 (18,924,000)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 256,520,000 $ 25,000